See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot3,994▼ 0.75%WTI103.27▲ 3.82%
← EBQ page
XStocksXray
Market X-Ray report · 23 October 2026

Ebiquity Plc (EBQ)

London Exchange · UK · prices in GBX · close of 23 Oct 2026

Key indicators

Last closeGBX 8.650
52-week range8.620 – 15.035
Return, 1 month / 3 months−11.3% / −7.7%
Return, 1 year / 3 years−40.3% / −75.6%
TrendBelow its 200-day average
RSI (14)5
Volatility (1 year)17.3%
Worst drawdown (1 year)-40.3%
Average daily value traded1.02M GBX
Dividend yield–

Market X-Ray price-based

36/ 100 · High confidence · ahead of 26% of stocks on this exchange
Trend16
Momentum20
Stability (higher is calmer)61
Liquidity53
Income–

Five-year price chart navy: price · brown: 200-day average

4.8822.4840.0757.6775.272021-102023-012024-042025-072026-10

About the company

Ebiquity is a marketing and media analytics consultancy based in London. It advises advertisers and brands on how their marketing and media spending performs, offering services such as media auditing, marketing effectiveness measurement, and analysis of advertising and media agency arrangements. Its clients are mainly large advertisers and brand owners who want independent evidence on the value and performance of their marketing investments across different media channels and markets.

Ebiquity Plc trades under the code EBQ on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Ebiquity Plc (EBQ) trades on the London Exchange in UK. It last closed at GBX 8.650 on 23 October 2026.

Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 2,818 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 40.3% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Ebiquity Plc (EBQ)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend16 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-21.1%
From 52-week high-40.3%
Momentum20 · WeakLagging most stocks on this exchange.
3-month return-7.7%
6-month return-24.1%
12-month return, skipping the last month-32.8%
Stability (higher is calmer)61 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)17.3%
Worst drawdown, 1 year (smaller is calmer)-40.3%
Liquidity53 · FairModerate trading activity.
Average daily value traded1.02M GBX
Zero-volume days8.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−5.2%
1 month−11.3%
3 months−7.7%
6 months−24.1%
1 year−40.3%
3 years−75.6%
5 years−84.1%

Signals

50-day / 200-day average9.524 / 10.969
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.252

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 0 neutral · 11 bearish
MonthlyStrongly bearish1 bullish · 0 neutral · 7 bearish

Recent dividends

Ex-dividend dateAmount per share
30 May 2019GBP 0.0071
29 May 2019GBP 0.5291

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 25 Oct 2026